Skip to main content

Table 1 Characteristics of the four medication risk communication methods included in this study [22, 23]

From: Enhancing medication risk communication in developing countries: a cross-sectional survey among doctors and pharmacists in Malaysia

 

Risk communication method

MADRAC Bulletin

Safety Alert

DHPC

Educational material

Author

NPRA

NPRA

Product registration holder, reviewed by NPRA

Product registration holder, NPRA, MOH

Target audience

Healthcare professionals

Healthcare professionals

Healthcare professionals

Healthcare professionals or patients

Dissemination method

• Email to healthcare professionals in NPRA mailing list, administrative heads of healthcare facilities, professional associations

• NPRA website

By product registration holder directly to healthcare professionals who use the product mentioned in DHPC

• By product registration holder or MOH directly to healthcare professionals

• By healthcare professionals to patients

Content

• Local ADR case reports

• MADRAC activities

• Latest pharmacovigilance activities

• Latest or emerging safety issues

• Summary of DHPCs

Important changes to medicinal product information.

Additional information to minimize risk of using the product, in addition to package insert information.

Frequency of publication

Every four months

As required, depending on emerging safety issues.

  1. ADR Adverse drug reaction; DHPC Direct Healthcare Professional Communication letter; MADRAC Malaysian Adverse Drug Reactions Advisory Committee; MOH Ministry of Health; NPRA National Pharmaceutical Regulatory Agency